Farovax CV 200mg/125mg Tablet is a combination antibiotic medication containing Faropenem (200mg) and Clavulanic Acid (125mg), designed to treat a variety of bacterial infections. Faropenem is a broad-spectrum carbapenem antibiotic that works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Clavulanic Acid acts as a beta-lactamase inhibitor, preventing bacterial enzymes from breaking down Faropenem, thereby enhancing its efficacy against beta-lactamase producing resistant strains. This synergistic combination makes Farovax CV effective against a wide range of gram-positive and gram-negative bacteria, including strains resistant to other antibiotics. It is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections. The tablet should be taken orally as directed by a healthcare professional, usually with or without food, to ensure optimal absorption. Patients should complete the full course of therapy even if symptoms improve early to prevent the development of resistance. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort. Farovax CV is contraindicated in individuals with known hypersensitivity to penicillins, carbapenems, or clavulanic acid. Consultation with a healthcare provider is essential before starting treatment to ensure appropriate use and dosing.